Education
About Us
Working with TipRanks
Follow Us
Renalytix (GB:RENX)
LSE:RENX
RENX Stock Chart & Stats
6.25p
0.99p(8.62%)
At close: 4:00 PM EST
6.25p
0.99p(8.62%)
Day’s Range― - ―
52-Week Range5.50p - 15.50p
Previous CloseN/A
Volume11.59K
Average Volume (3M)10.03M
Market Cap
$31.68M
Enterprise Value34.47M
Total Cash (Recent Filing)$9.63M
Total Debt (Recent Filing)$8.21M
Price to Earnings (P/E)―
Beta0.29
Next Earnings
Mar 26, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding437,018,680
10 Day Avg. Volume3,807,103
30 Day Avg. Volume10,033,489
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap1.09
Enterprise Value/Revenue14.53
Enterprise Value/Gross Profit73.65
Enterprise Value/Ebitda-1.49
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Renalytix News
RENX FAQ
What was Renalytix’s price range in the past 12 months?
Renalytix lowest share price was 5.50p and its highest was 15.50p in the past 12 months.
What is Renalytix’s market cap?
Renalytix’s market cap is $31.68M.
When is Renalytix’s upcoming earnings report date?
Renalytix’s upcoming earnings report date is Mar 26, 2026 which is in 103 days.
How were Renalytix’s earnings last quarter?
Currently, no data Available
Is Renalytix overvalued?
According to Wall Street analysts Renalytix’s price is currently Overvalued.
Does Renalytix pay dividends?
Renalytix does not currently pay dividends.
What is Renalytix’s EPS estimate?
Renalytix’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Renalytix have?
Renalytix has 437,018,680 shares outstanding.
What happened to Renalytix’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Renalytix?
Currently, no hedge funds are holding shares in GB:RENX
Company Description
Renalytix
Renalytix (RENX) is a healthcare technology company specializing in the development of diagnostic solutions for kidney disease. Operating within the biotechnology and medical diagnostics sectors, the company focuses on providing innovative tools that improve early detection, monitoring, and treatment of kidney disease. Renalytix's core products include KidneyIntelX, a proprietary AI-driven in vitro diagnostic platform that assesses the risk of progressive kidney function decline in patients with chronic kidney disease (CKD).
Technical Analysis
Options Prices
Currently, No data available
---